These standards apply to the examination of existing health claims and to the discussion of emerging science, technologies, and possible future developments alike.
Every factual statement published under the Sacapuntas Publishing name is traceable to an identifiable source: a peer-reviewed study, a systematic review, data from a regulatory or institutional survey, or a position issued by a recognised body such as the WHO, EFSA, or FDA.
Evidence does not always lead to a single verdict. It exists in layers. Mechanistic research, cell and animal studies, observational cohorts, randomised controlled trials, systematic reviews, real-world evidence, and practical experience. Each layer has a legitimate role. Each also has limits.
A mechanistic finding may provide a sound basis for a hypothesis without demonstrating an effect in humans. An observational association may justify further investigation or caution without establishing cause and effect. A controlled trial may demonstrate efficacy under defined conditions without showing how an intervention performs in everyday use. What changes between these layers is not whether they count as evidence, but which conclusions they can responsibly support.
The appropriate evidentiary standard also depends on the decision being made. A public health recommendation intended for millions of people requires greater certainty than an individual weighing a low-risk choice in their own circumstances. Identifying the level of evidence behind a statement, and explaining what that evidence can and cannot establish, is therefore part of the statement itself.
Writing about innovation requires an additional distinction. Emerging developments tend to come with incomplete evidence, uncertain timelines, and several possible outcomes. Sacapuntas Publishing examines their scientific plausibility, potential applications, regulatory implications, and likely impact. None of that is presented as prediction or as established fact.
Where a statement rests primarily on interpretation, extrapolation, estimation, a future scenario, or informed speculation, it is identified as such. The assumptions behind it are stated, together with the evidence it draws on, the uncertainties involved, and what would have to happen for the development to become practical reality. Early evidence is not presented as proof of eventual success. Nor is uncertainty treated as evidence that an innovation has no value.
Sacapuntas Publishing is not a marketing channel. It does not accept sponsored content presented as independent review, and it does not recommend products in exchange for payment. Where professional experience, industry relationships, or other interests could reasonably be perceived as a conflict, they are disclosed rather than left unmentioned. Being open about where expertise comes from, and about what might bias it, is itself part of responsible evidence communication.
Working principles
Traceability. Factual statements are linked to identifiable and appropriate sources.
Evidence level. The type, quality, and maturity of the evidence are stated, not blurred together.
Fact, interpretation, and speculation. Established findings, editorial interpretation, projection, and informed speculation are kept visibly apart.
Causality. Association, biological plausibility, mechanism, and cause and effect are not treated as interchangeable.
Proportionality. The strength of the language matches the strength of the evidence.
Context and limitations. Study design, population, sample size, uncertainty, funding, and applicability are reported where they bear on the conclusion.
Innovation and foresight. Emerging developments may be discussed before the evidence is complete, provided the assumptions and evidentiary gaps are made explicit.
Independence. No sponsored material presented as independent review. No paid product recommendations.
Corrections. Material errors are corrected in the article itself, with a dated note recording what changed. Conclusions are revised when better evidence or later developments alter the picture.